TARSONS PRODUCTS LIMITED
TARSONS · General/Diversified · NSE
₹214
Current Market Price
Fair Value (DCF)
₹286
Margin of Safety
+33.6%
Updated 10h ago
YieldIQ Score
44/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
17%
ROE
—
Debt/Equity
0.63
WACC
11.1%
Market Cap
₹1,139 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
7.1%
Return on capital employed
EV / EBITDA
14.7×
Enterprise multiple
Debt / EBITDA
3.3×
Leverage vs earnings
Interest Coverage
3.3×
EBIT covers interest
Current Ratio
1.38×
Short-term liquidity
Asset Turnover
0.36×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹214.08
Bear case
₹168.76
MoS -26.9%
Base case
₹286
MoS +25.1%
Bull case
₹286
MoS +25.1%
Ratio Trends
TARSONS · last 4 annual periods
ROE
4.7%
ROCE
13.1%
Operating Margin
—
Debt / Equity
0.54×
PE
124.1×
EV / EBITDA
19.8×
Historical Financials
TARSONS · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹301 Cr | ₹82.1 Cr | ₹106 Cr | ₹391 Cr | +9.1% |
| EBITDA | ₹161 Cr | ₹142 Cr | ₹111 Cr | ₹127 Cr | -7.7% |
| EBIT | ₹139 Cr | ₹33.2 Cr | ₹21.3 Cr | — | -46.5% |
| PAT | ₹101 Cr | ₹22.8 Cr | ₹10.3 Cr | ₹29.8 Cr | -33.4% |
| EPS (diluted) | ₹19.46 | ₹4.29 | ₹1.94 | — | -53.6% |
| CFO | ₹83.5 Cr | ₹75.6 Cr | ₹103 Cr | ₹114 Cr | +11.0% |
| CapEx | — | — | — | ₹-152 Cr | — |
| FCF | — | — | — | ₹-37.5 Cr | — |
| Total Assets | ₹544 Cr | ₹726 Cr | ₹972 Cr | ₹1080 Cr | +25.7% |
| Total Debt | — | ₹29.9 Cr | ₹155 Cr | ₹339 Cr | +124.6% |
| Shareholders' Equity | — | ₹569 Cr | ₹613 Cr | ₹630 Cr | +3.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
TARSONS vs 1 closest peer by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| LAXMIDENTL LAXMIDENTL | — | — | Pending | 15.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for TARSONS in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of TARSONS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for TARSONS →
Compare
Head-to-head with peers
Compare TARSONS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse TARSONSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.